Collaborations are key in achieving scientific progress. The European Horizon COST Actions provide great opportunities to build, grant, and/or participate in pan-European collaborations in multidisciplinary topics, including liver diseases.

This EASL Studio:

  • Provides you with information about the COST Action programme.
  • Discusses the structure of the drug-induced liver injury (DILI) and cholangiocarcinoma (CCA) working groups.
  • Highlights the potential for collaborative work within this programme.


  • Prof. Jesús Bañales (Moderator)
  • Prof. Raul Andrade (Faculty)
  • Dr Chiara Braconi (Faculty)
  • Prof. Vincenzo Cardinale (Faculty)

Related episodes

  • S4E13: EASL-EF CLIF and EU Grants: Exploring novel mechanisms and treatment of chronic liver failure
  • S4E2: YI Choice: How to build consortia and registries

ℹ️ Please click here to access the podcast version of this EASL Studio episode.


Log in to post comments